Evidence map›Paper›PMID 24046361›Full record

ArticleDisease models & mechanisms2013

Sestrin-2, a repressor of PDGFRβ signalling, promotes cigarette-smoke-induced pulmonary emphysema in mice and is upregulated in individuals with COPD.

Juliana Heidler, Athanasios Fysikopoulos, Frank Wempe, Michael Seimetz, Thorsten Bangsow, Ana Tomasovic, Florian Veit, Susan Scheibe, Alexandra Pichl, Friederike Weisel and 5 more

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Targeting NRF2 to promote epithelial repair.Biochemical Society transactions · 2023
    Review
  4. Article
  5. The functions and roles of sestrins in regulating human diseases.Cellular & molecular biology letters · 2022
    Review
  6. Article
  7. Sestrin2 in hypoxia and hypoxia-related diseases.Redox report : communications in free radical research · 2021
    Review
  8. Sestrin2 and Beclin1 levels in Polycystic Ovary Syndrome.Journal of clinical laboratory analysis · 2021
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Sestrin2 is involved in asthma: a case-control study.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2019
    Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Juliana HeidlerDepartment of Molecular Haematology, Goethe University Medical School, D-60590 Frankfurt am Main, Germany.
Athanasios Fysikopoulos
Frank Wempe
Michael Seimetz
Thorsten Bangsow
Ana Tomasovic
Florian Veit
Susan Scheibe
Alexandra Pichl
Friederike Weisel
K C Kent Lloyd
Peter Jaksch
Walter Klepetko
Norbert Weissmann
Harald von Melchner
Goethe University Frankfurt · DEUniversity of Giessen · DEUniversities of Giessen and Marburg Lung Center · DEVienna General Hospital · ATUniversity of California, Davis · US

Funding

UCD Mutant Mouse Regional Resource CenterU42OD012210 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KC KENT LLOYD · 2012 to 2026
$29.2M
KOMP Phase II Mouse Production and CryopreservationU42OD011175 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LLOYD, KC KENT · 2012 to 2015
$18.9M
KOMP Phase II Mouse PhenotypingU54HG006364 · NHGRI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LLOYD, KC KENT · 2011 to 2015
$16.3M
NHGRI NIH HHS U54 HG006364NIH HHS U42 OD011175NIH HHS U42 OD012210
6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. COPD is caused by chronic exposure to cigarette smoke and/or other environmental pollutants that are believed to induce reactive oxygen species (ROS) that gradually disrupt signalling pathways responsible for maintaining lung integrity. Here we identify the antioxidant protein sestrin-2 (SESN2) as a repressor of PDGFRβ signalling, and PDGFRβ signalling as an upstream regulator of alveolar maintenance programmes. In mice, the mutational inactivation of Sesn2 prevents the development of cigarette-smoke-induced pulmonary emphysema by upregulating PDGFRβ expression via a selective accumulation of intracellular superoxide anions (O2(-)). We also show that SESN2 is overexpressed and PDGFRβ downregulated in the emphysematous lungs of individuals with COPD and to a lesser extent in human lungs of habitual smokers without COPD, implicating a negative SESN2-PDGFRβ interrelationship in the pathogenesis of COPD. Taken together, our results imply that SESN2 could serve as both a biomarker and as a drug target in the clinical management of COPD.

Indexed as

SmokeUp-RegulationAnimalsHumansLungMiceMice, KnockoutNuclear ProteinsPeroxidasesPulmonary Disease, Chronic ObstructivePulmonary EmphysemaReceptor, Platelet-Derived Growth Factor betaSestrinsSignal TransductionSuperoxidesNuclear ProteinsPeroxidasesReceptor, Platelet-Derived Growth Factor betaSESN2 protein, humanSesn2 protein, mouseSestrinsSmokeSuperoxides

Identifiers

PMID24046361
PMCPMC3820261
OpenAlexW2150746703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.